群发资讯网

返回主页
taxanes
紫杉烷
常用释义
英式发音
美式发音
基本释义
  • 紫杉烷
例句
  • 1·Taxanes are highly active chemotherapy agents in metastatic breast cancer.
    紫杉醇类药物是治疗转移性乳癌的高度活跃的化疗药物。
  • 2·Drug resistance is the main restriction factor for clinical usage of taxanes.
    耐药是影响紫杉类药物临床疗效的重要因素。
  • 3·Effect of gibberellin and chlorocholine chloride on taxanes production was investigated.
    考察了矮壮素和赤霉素对细胞培养生产紫杉烷的影响。
  • 4·If the patient were to be treated without taxanes, I would favor 6 cycles of CAF or CEF.
    如果这个患者要担当非紫杉类的治疗,我倾向于应用6个周期的CAF或CEF计划。
  • 5·Between the two taxanes, both Taxol and Taxotere are reasonable options to combine with Adriamycin for our patient.
    在2个紫杉类药物中,泰素和泰索帝与阿霉素联合均为合理的选择。
  • 6·Taxanes have good antineoplastic activity, but the clinical application has been limited owing to the poor water solubility.
    紫杉烷类药物具有良好的抗肿瘤活性,然而其极差的水溶性却限制了临床应用。
  • 7·Analytical method was developed for the trace analysis of taxanes in crude extraction and identification of the antitumor agent paclitaxel.
    建立了一套利用反相高效液相色谱和大气压化学电离质谱联用技术分析红豆杉提取物中微量紫杉烷类化合物的方法。
  • 8·Women with breast cancer who receive drugs known as taxanes after standard chemotherapy have a substantially reduced risk of recurrence and of death.
    患乳腺癌的妇女接受有名的紫杉烷类药物的标准化疗后能实质性的降低复发和死亡的危险。
  • 9·Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
    紫杉醇与S-1作为转移性乳腺癌的一线化疗(选择BC):一项开放标签、非劣效性、随机3期试验。
  • 10·The paper reviews the commercial preparations of taxanes and preparations on different development stage, and predicts the further progress direction.
    该文简要综述了现已上市紫杉烷类制剂和处于各研发阶段制剂的研究进展,展望了紫杉烷类抗肿瘤药物研究的方向。